Evaluation of quantitative MRCP (MRCP+) for risk stratification of primary sclerosing cholangitis: comparison with morphological MRCP, MR elastography, and biochemical risk scores

[1]  S. Serai,et al.  Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver Disease , 2020, Hepatology communications.

[2]  J. Brady,et al.  Quantitative MRCP Imaging: Accuracy, Repeatability, Reproducibility, and Cohort‐Derived Normative Ranges , 2020, Journal of magnetic resonance imaging : JMRI.

[3]  K. Jhaveri,et al.  Risk stratification in primary sclerosing cholangitis: comparison of biliary stricture severity on MRCP versus liver stiffness by MR elastography and vibration-controlled transient elastography , 2020, European Radiology.

[4]  A. Bergquist,et al.  Inter-reader agreement of interpretation of radiological course of bile duct changes between serial follow-up magnetic resonance imaging/3D magnetic resonance cholangiopancreatography of patients with primary sclerosing cholangitis , 2020, Scandinavian journal of gastroenterology.

[5]  J. Barkun,et al.  Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  A. Floreani,et al.  The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis. , 2019, The American journal of gastroenterology.

[7]  R. Chapman,et al.  Evolving role of magnetic resonance techniques in primary sclerosing cholangitis , 2019, World journal of gastroenterology.

[8]  G. Gores,et al.  Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes of the Disease: A Derivation and Validation Study Using Machine Learning , 2020, Hepatology.

[9]  K. Lindor,et al.  Primary Sclerosing Cholangitis, Part 2: Cancer Risk, Prevention, and Surveillance. , 2018, Gastroenterology & hepatology.

[10]  A. Lohse,et al.  Follow‐up magnetic resonance imaging/3D‐magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret , 2018, Alimentary pharmacology & therapeutics.

[11]  J. Han,et al.  Liver Stiffness Measured by Two-Dimensional Shear-Wave Elastography: Prognostic Value after Radiofrequency Ablation for Hepatocellular Carcinoma , 2018, Liver Cancer.

[12]  Junfeng Wang,et al.  A novel prognostic model for transplant-free survival in primary sclerosing cholangitis , 2017, Gut.

[13]  T. Karlsen,et al.  Primary sclerosing cholangitis - a comprehensive review. , 2017, Journal of hepatology.

[14]  S. Venkatesh,et al.  Recommendations on the use of magnetic resonance imaging in PSC‐A position statement from the International PSC Study Group , 2017, Hepatology.

[15]  P. Schirmacher,et al.  Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study , 2017, Hepatology.

[16]  F. Carrat,et al.  AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Radiologic Course of Primary Sclerosing Cholangitis: Assessment by Three-Dimensional Magnetic Resonance Cholangiography and Predictive Features of Progression , 2013 .

[17]  T. Karlsen,et al.  Primary sclerosing cholangitis , 2001, The Lancet.

[18]  S. Vowler,et al.  Categorized or continuous? Strength of an association – and linear regression , 2012, The Journal of physiology.

[19]  G. Gores,et al.  Diagnosis and management of primary sclerosing cholangitis , 2010, Hepatology.

[20]  T. Therneau,et al.  A revised natural history model for primary sclerosing cholangitis. , 1997, Mayo Clinic proceedings.